Microba Life Sciences Limited (ASX:MAP)
Australia flag Australia · Delayed Price · Currency is AUD
0.0810
-0.0010 (-1.22%)
At close: Mar 9, 2026

Microba Life Sciences Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2019
Market Capitalization
49447210355-
Upgrade
Market Cap Growth
-55.94%-38.91%-30.59%88.15%--
Upgrade
Enterprise Value
4130456246-
Upgrade
Last Close Price
0.080.090.160.280.19-
Upgrade
PS Ratio
3.312.795.9319.0511.70-
Upgrade
PB Ratio
1.631.351.742.681.64-
Upgrade
P/TBV Ratio
5.744.263.302.691.65-
Upgrade
EV/Sales Ratio
2.721.903.7211.539.77-
Upgrade
Debt / Equity Ratio
0.080.100.040.030.040.02
Upgrade
Net Debt / Equity Ratio
-0.29-0.27-0.47-0.81-0.88-0.85
Upgrade
Net Debt / EBITDA Ratio
0.380.390.821.631.891.43
Upgrade
Net Debt / FCF Ratio
0.570.701.142.402.441.72
Upgrade
Asset Turnover
0.320.300.230.130.160.26
Upgrade
Inventory Turnover
3.783.944.285.465.323.97
Upgrade
Quick Ratio
1.431.572.365.056.504.38
Upgrade
Current Ratio
1.731.872.615.316.804.84
Upgrade
Return on Equity (ROE)
-59.98%-40.54%-49.98%-35.17%-47.33%-66.46%
Upgrade
Return on Assets (ROA)
-32.54%-28.99%-30.57%-29.26%-35.09%-40.63%
Upgrade
Return on Capital Employed (ROCE)
-72.10%-66.00%-55.80%-51.70%-47.60%-62.90%
Upgrade
Earnings Yield
-40.05%-34.13%-27.82%-12.28%-20.90%-
Upgrade
FCF Yield
-31.19%-28.18%-23.80%-12.54%-22.02%-
Upgrade
Buyback Yield / Dilution
-15.66%-9.40%-30.42%-40.87%-21.61%-17.01%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.